Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction.

Trial Profile

Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Recombinant erythropoietin (Primary)
  • Indications Myocardial infarction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top